Galenica AG (SWX:GALE)
Switzerland · Delayed Price · Currency is CHF 89.40
+0.60 (0.68%)
Oct 21, 2025, 5:31 PM CET
Galenica AG Revenue
Galenica AG had revenue of 2.00B CHF in the half year ending June 30, 2025, with 7.77% growth. This brings the company's revenue in the last twelve months to 4.03B, up 5.91% year-over-year. In the year 2024, Galenica AG had annual revenue of 3.93B with 4.65% growth.
Revenue (ttm)
4.03B
Revenue Growth
+5.91%
P/S Ratio
1.10
Revenue / Employee
504.07K
Employees
7,971
Market Cap
4.42B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.93B | 174.55M | 4.65% |
| Dec 31, 2023 | 3.76B | 160.81M | 4.47% |
| Dec 31, 2022 | 3.60B | -246.19M | -6.41% |
| Dec 31, 2021 | 3.84B | 356.57M | 10.23% |
| Dec 31, 2020 | 3.48B | 178.60M | 5.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Roche Holding AG | 63.49B |
| Novartis AG | 43.89B |
| Sandoz Group AG | 8.42B |
| Alcon | 7.97B |
| Lonza Group AG | 7.09B |
| Sonova Holding AG | 3.87B |
| Galderma Group AG | 3.73B |
| Straumann Holding AG | 2.58B |